Feb 12 (Reuters)-
Cosmo Bio Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2020 Dec 31, 2019 Dec 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 8.09 7.59 8.20 4.00
(+6.6 pct) (+4.5 pct) (+1.3 pct) (+1.4 pct)
Operating 752 mln 405 mln 700 mln 370 mln
(+85.6 pct) (+23.5 pct) (-7.0 pct) (-14.3 pct)
Recurring 817 mln 470 mln 750 mln 410 mln
(+73.7 pct) (+16.5 pct) (-8.3 pct) (-15.0 pct)
Net
Net 674 mln 237 mln 480 mln 260 mln
(+183.2 pct) (-8.6 pct) (-28.8 pct) (-42.3 pct)
EPS 113.70 yen 40.14 yen 80.97 yen 43.86 yen
Ann Div 34.00 yen 14.00 yen 26.00 yen
-Q2 Div 8.00 yen 6.00 yen 12.00 yen
-Q4 Div 26.00 yen 8.00 yen 14.00 yen
NOTE - Cosmo Bio Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T